PCA
PLRX icon

Personal Capital Advisors’s Pliant Therapeutics PLRX Stock Holding History

Personal Capital Advisors’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$209K Buy
+10,790
New +$226K ﹤0.01% 456

Other funds holding PLRX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CA
CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $624M AUM 250.2% 1-Year Est. Return
TGI
TRV GP IV Boston, Massachusetts $254M AUM 426.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGI
TRV GP III Boston, Massachusetts $6.14M AUM 45.44% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return

Personal Capital Advisors's PLRX Position: Q4 2022 in Review

Personal Capital Advisors opened a new position in Pliant Therapeutics (PLRX) in Q4 2022: 10,790 shares worth $209K. The stake represents ﹤0.01% of the portfolio and ranks #456 among its holdings.

123 funds tracked by Wall St. Rank hold PLRX as of Q4 2022.

  • Personal Capital Advisors held 10,790 shares of Pliant Therapeutics worth $209K as of Q4 2022.
  • Pliant Therapeutics was a new Personal Capital Advisors position in Q4 2022.
  • Pliant Therapeutics made up ﹤0.01% of Personal Capital Advisors's portfolio in Q4 2022, its #456 holding.
  • 123 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q4 2022.

Based on Personal Capital Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.